Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| 1,?2,?3,?4-?Tetrahydro-?N,?N,?6-?trimethyl-1,?7-?naphthyridin-?8-?amine | 1,?2,?3,?4-?Tetrahydro-?N,?N,?6-?trimethyl-1,?7-?naphthyridin-?8-?amine is a useful synthetic intermediate. Group: Biochemicals. Grades: Highly Purified. CAS No. 1820639-42-6. Pack Sizes: 25mg, 50mg. Molecular Formula: C11H17N3, Molecular Weight: 191.27. US Biological Life Sciences. |  Worldwide |
| 1,7-Naphthyridin-8-amine | 1g Pack Size. Group: Amines, Research Organics & Inorganics. Formula: C8H7N3. CAS No. 17965-82-1. Prepack ID 90027766-1g. Molecular Weight 145.17. See USA prepack pricing. |  |
| 2-(tert-Butyl)-1,6-naphthyridin-5-amine | 2-(tert-Butyl)-1,6-naphthyridin-5-amine is used as a reactant in the preparation of organic light emitting devices. Group: Biochemicals. Grades: Highly Purified. CAS No. 1352329-32-8. Pack Sizes: 25mg, 250mg. Molecular Formula: C12H15N3, Molecular Weight: 201.27. US Biological Life Sciences. | Worldwide |
| 3-(3-Methyl-1,6-naphthyridin-2-yl)-1,2,4-thiadiazol-5-amine | Heterocyclic Organic Compound. Alternative Names: 3-(3-methyl-1,6-naphthyridin-2-yl)-1,2,4-thiadiazol-5-amine, AKOS015842316, DB-061114, KB-232966, TC-067833, 1179360-49-6. CAS No. 1179360-49-6. Molecular formula: C11H9N5S. Mole weight: 243.287660 [g/mol]. Purity: 0.96. IUPACName: 3-(3-methyl-1,6-naphthyridin-2-yl)-1,2,4-thiadiazol-5-amine. Canonical SMILES: CC1=C(N=C2C=CN=CC2=C1)C3=NSC(=N3)N. Catalog: ACM1179360496. |  |
| 3-(7-Methyl-1,8-naphthyridin-2-yl)-1,2,4-thiadiazol-5-amine | Heterocyclic Organic Compound. Alternative Names: 3-(7-methyl-1,8-naphthyridin-2-yl)-1,2,4-thiadiazol-5-amine, AKOS015842562, DB-061190, KB-233395, TC-067834, 1179362-11-8. CAS No. 1179362-11-8. Molecular formula: C11H9N5S. Mole weight: 243.287660 [g/mol]. Purity: 0.96. IUPACName: 3-(7-methyl-1,8-naphthyridin-2-yl)-1,2,4-thiadiazol-5-amine. Canonical SMILES: CC1=NC2=C(C=C1)C=CC(=N2)C3=NSC(=N3)N. Catalog: ACM1179362118. | |
| 3-Bromo-1,6-naphthyridin-5-amine | 3-Bromo-1,6-naphthyridin-5-amine. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 5mg. Molecular Formula: C8H6BrN3, Molecular Weight: 224.06. US Biological Life Sciences. | Worldwide |
| 5,6,7,8-Tetrahydro-2,6-naphthyridin-1-amine | 5,6,7,8-Tetrahydro-2,6-naphthyridin-1-amine. Group: Biochemicals. Alternative Names: 5,6,7,8-Tetrahydro-[2,6]naphthyridin-1-amine. Grades: Highly Purified. CAS No. 601515-40-6. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C8H11N3. US Biological Life Sciences. | Worldwide |
| 6-(Benzo[d]oxazol-2-yl)-1,8-naphthyridin-2-amine | Heterocyclic Organic Compound. CAS No. 1027511-48-3. Molecular formula: C15H10N4O. Mole weight: 262.2661;g/mol. Purity: 0.96. IUPACName: 6-(1,3-benzoxazol-2-yl)-1,8-naphthyridin-2-amine. Canonical SMILES: C1=CC=C2C (=C1)N=C (O2)C3=CN=C4C (=C3)C=CC (=N4)N. Catalog: ACM1027511483. | |
| AR03 | AR03 is a specific inhibitor of apurinic/apyrimidinic (AP) endonuclease 1 (APE1). Synonyms: BMH-23; BMH 23; BMH23; AR03; AR 03; AR-03; 2,4,9-trimethylbenzo[b][1,8]naphthyridin-5-amine. Grades: 99%. CAS No. 510721-85-4. Molecular formula: C15H15N3. Mole weight: 237.3. |  |
| Epetirimod | Epetirimod is a small-molecule immune-response modifier intended for the topical treatment of cervical human papilloma virus (HPV) infection and cervical dysplasia. Synonyms: S-30563; S 30563; S30563; 1-(2-methylpropyl)imidazo[4,5-c][1,5]naphthyridin-4-amine; Epetirimod. Grades: >98%. CAS No. 227318-71-0. Molecular formula: C13H15N5. Mole weight: 241.298. | |
| 1,8-Naphthyridine-3-carboxylicacid,7-(3-amino-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo- | Heterocyclic Organic Compound. Alternative Names: 1, 8-naphthyridine-3-carboxylicacid, 1, 4-dihydro-7-(3-amino-1-pyrrolidinyl)-1-(; 4-difluorophenyl)-6-fluoro-4-oxo-; a61827; a67107; abbott61827; 1-(2, 4-Difluorophenyl)-6-fluoro-1, 4-dihydro-7-(3-aminopyrrolidin-1-yl)-4-oxo-1, 8-naphthyridine-3-carboxylic acid;1,8. CAS No. 100490-36-6. Molecular formula: C19H15F3N4O3. Mole weight: 404.3426. Appearance: White powder. Purity: 0.96. IUPACName: 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Canonical SMILES: C1CN (CC1N)C2=C (C=C3C (=O)C (=CN (C3=N2)C4=C (C=C (C=C4)F)F)C (=O)O)F. Density: 1.558 g/cm³. Catalog: ACM100490366. | |
| 1-? (Phenyl methyl ) ?-?2-? [ (tri phenylphosphora?nylide ne ) ?amino] ?-1H-?indole-?3-?carboxalde hyde | 1-? (Phenyl methyl ) ?-?2-? [ (tri phenylphosphora?nylide ne ) ?amino] ?-1H-?indole-?3-?carboxalde hyde is an intermediate in synthesizing 2,3,4,10-Tetrahydro-1H-indolo[2,3-b][1,8]naphthyridin-2-ol (T294270), a derivative of 6, 7, 8, 9-Tetrahydro-7-hydroxy-5-methyl-3-phenyl-pyrido[3, 2:4, 5]imidazo[1, 2-a]pyrimidinium Chloride (H957770), a carcinogen used in the study of intestinal bacteria metabolism. Created through the heat processing of food. Group: Biochemicals. Grades: Highly Purified. CAS No. 134370-12-0. Pack Sizes: 50mg, 100mg. Molecular Formula: C34H27N2OP. US Biological Life Sciences. | Worldwide |
| 2-Amino-[1,8]naphthyridine-3-carbonitrile | 2-Amino-[1,8]naphthyridine-3-carbonitrile. Group: Biochemicals. Grades: Highly Purified. CAS No. 15935-95-2. Pack Sizes: 100mg, 250mg. Molecular Formula: C9H6N4, Molecular Weight: 170.17. US Biological Life Sciences. | Worldwide |
| 2-?Amino-?1-?(phenylmethyl)?-1H-?indole-?3-?carboxaldehyde | 2-?Amino-?1-?(phenylmethyl)?-1H-?indole-?3-?carboxaldehyde is an intermediate in synthesizing 2,3,4,10-Tetrahydro-1H-indolo[2,3-b][1,8]naphthyridin-2-ol (T294270), a derivative of 6, 7, 8, 9-Tetrahydro-7-hydroxy-5-methyl-3-phenyl-pyrido[3, 2:4, 5]imidazo[1, 2-a]pyrimidinium Chloride (H957770), a carcinogen used in the study of intestinal bacteria metabolism. Created through the heat processing of food. Group: Biochemicals. Grades: Highly Purified. CAS No. 126177-49-9. Pack Sizes: 5mg, 10mg. Molecular Formula: C16H14N2O. US Biological Life Sciences. | Worldwide |
| 2-Amino-5-methylnicotinaldehyde | 2-Amino-5-methylnicotinaldehyde is a reactant used in the preparation of naphthyridines by Cu-catalyzed hydroamination / Friedlander reaction with terminal alkynes. Group: Biochemicals. Grades: Highly Purified. CAS No. 1023814-35-8. Pack Sizes: 10mg, 25mg. Molecular Formula: C7H8N2O, Molecular Weight: 136.15. US Biological Life Sciences. | Worldwide |
| 2-Amino-5-methylnicotinaldehyde | A reagent used in the preparation of naphthyridines by Cu-catalyzed hydroamination/Friedlander reaction with terminal alkynes. Synonyms: 2-amino-5-methylpyridine-3-carbaldehyde. CAS No. 1023814-35-8. Molecular formula: C7H8N2O. Mole weight: 136.15. | |
| 2-Amino-6-iodo-[1,8]naphthyridine-3-carbonitrile | 2-Amino-6-iodo-[1,8]naphthyridine-3-carbonitrile is used in the modification of radioiodination targets. Group: Biochemicals. Grades: Highly Purified. CAS No. 578007-69-9. Pack Sizes: 25mg, 50mg. Molecular Formula: C9H5IN4, Molecular Weight: 296.07. US Biological Life Sciences. | Worldwide |
| 2-Amino-6-methyl-1,8-naphthyridine-3-carbonitrile | 2-Amino-6-methyl-1,8-naphthyridine-3-carbonitrile. Group: Biochemicals. Grades: Highly Purified. CAS No. 1203499-48-2. Pack Sizes: 10mg, 25mg. Molecular Formula: C10H8N4, Molecular Weight: 184.2. US Biological Life Sciences. | Worldwide |
| 2-? Amino-? 7-? chloro-? 1-? ethyl-? N-? methyl-? 4-? oxo-? 1, ? 4-? dihydro-? 1, ? 8-? naphthyridine-? 3-? carboxamide | 2-Amino-7-chloro-1-ethyl-1,4-dihydro-N-methyl-4-oxo-1,8-naphthyridine-3-carboxamide is an intermediate in the synthesis of SAR131675 (S139510), is a potent and selective VEGFR-3 inhibitor. Group: Biochemicals. Alternative Names: 2-Amino-7-chloro-1-ethyl-1,4-dihydro-N-methyl-4-oxo-1,8-naphthyridine-3-carboxamide. Grades: Highly Purified. CAS No. 1092523-24-4. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| 6-Methoxy-1,5-naphthyridine-4-boronicacid | Boro-Amino Acids. CAS No. 1257640-81-5. Catalog: ACM1257640815. | |
| 7-[(3S)-3-Aminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid | Heterocyclic Organic Compound. CAS No. 127967-03-7. Molecular formula: C16H17FN4O3. Mole weight: 332.33 g/mol. Catalog: ACM127967037. | |
| 7-Amino-4-methyl-[1,8]naphthyridin-2-ol | 7-Amino-4-methyl-[1,8]naphthyridin-2-ol. Group: Biochemicals. Grades: Highly Purified. CAS No. 1569-15-9. Pack Sizes: 500mg, 1g, 2g, 5g, 10g. US Biological Life Sciences. | Worldwide |
| 8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naphthyridin-3(2H)-one | Heterocyclic Organic Compound. Alternative Names: UNII-51HZG6MP1K; MK-2206 dihydrochloride. CAS No. 1032349-93-1. Molecular formula: C25H21N5O. Mole weight: 407.467140 [g/mol]. Purity: 0.96. IUPACName: 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one. Catalog: ACM1032349931. | |
| Afabicin | Afabicin (formerly Debio 1450, AFN-1720) is a prodrug of afabicin desphosphono, an enoyl-acyl carrier protein reductase (FabI) inhibitor, and is a first-in-class antibiotic with a novel mode of action to specifically target fatty acid synthesis in Staphylococcus spp. Group: Inhibitors. Alternative Names: Afabicin; Debio 1450; Debio-1450; Debio1450; AFN-1720; AFN 1720; AFN1720. CAS No. 1518800-35-5. Molecular formula: C23H24N3O7P. Mole weight: 485.43. Appearance: Solid powder. Purity: >98%. IUPACName: (E)-(6-(3-(methyl((3-methylbenzofuran-2-yl)methyl)amino)-3-oxoprop-1-en-1-yl)-2-oxo-3,4-dihydro-1,8-naphthyridin-1(2H)-yl)methyl dihydrogen phosphate. Canonical SMILES: O=P (O) (OCN1C (CCC2=CC (/C=C/C (N (C)CC (O3)=C (C)C4=C3C=CC=C4)=O)=CN=C12)=O)O. Catalog: ACM1518800355. | |
| Alatrofloxacin Mesylate | Alatrofloxacin Mesylate is the mesylate salt form of the fluoroquinolone derivative Alatrofloxacin, a type II DNA topoisomerase inhibitor that has been developed as an antibacterial agent. Synonyms: L-Alaninamide, L-alanyl-N-[(1α,5α,6α)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]-, methanesulfonate (1:1); L-Alaninamide, L-alanyl-N-[(1α,5α,6α)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]-, monomethanesulfonate; L-Alaninamide, L-alanyl-N-[3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]-, (1α,5α,6α)-, monomethanesulfonate; Adrenochrome monoaminoguanidine mesilate; CP 116517; CP 116517-27; Trovan IV; Turvel IV; 7-((1R,5S,6s)-6-((S)-2-((S)-2-aminopropanamido)propanamido)-3-azabicyclo[3.1.0]hexan-3-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid compound with methanesulfonic acid (1:1). Grades: ≥95%. CAS No. 146961-77-5. Molecular formula: C27H29F3N6O8S. Mole weight: 654.61. | |
| Alatrofloxacin Mesylate | Alatrofloxacin Mesylate. Uses: For analytical and research use. Group: Chiral molecules. Alternative Names: 3-Azabicyclo[3.1.0]hexane, L-alaninamide deriv., CP 116517, L-Alaninamide, L-alanyl-N-[3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]-, (1α,5α,6α)-, monomethanesulfonate, CP 116517-27, L-Alaninamide, L-alanyl-N-[(1α,5α,6α)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]-, monomethanesulfonate (9CI), Adrenochrome monoaminoguanidine mesilate, Alatrofloxacin mesylate,Alatrofloxacin Mesylate, L-Alaninamide, L-alanyl-N-[(1α,5α,6α)-3-[6-carboxy-8-(2,4-difluorophenyl)-3-fluoro-5,8-dihydro-5-oxo-1,8-naphthyridin-2-yl]-3-azabicyclo[3.1.0]hex-6-yl]-, methanesulfonate (1:1). CAS No. 146961-77-5. IUPAC Name: 7- [ (1R, 5S) -6- [ [ (2S) -2- [ [ (2S) -2-aminopropanoyl] amino] propanoyl] amino] -3-azabicyclo [3. 1. 0] hexan-3-yl] -1- (2, 4-difluorophenyl) -6-fluoro-4-oxo-1, 8-naphthyridine-3-carboxylic acid;methanesulfonic acid. Molecular Formula: C26H25F3N6O5.CH4O3S. Mole Weight: 654.61. Catalog: APS146961775. SMILES: C[C@H] (N)C (=O)N[C@@H] (C)C (=O)N[C@H]1[C@@H]2CN (C[C@H]12)c3nc4N (C=C (C (=O)O)C (=O)c4cc3F)c5ccc (F)cc5F. CS (=O) (=O)O. Format: Neat. |  |
| CP 99433 | CP 99433, a fluoroquinolone derivative, has been found to be a Type II DNA topoisomerase inhibitor that could be probably effective as an antibacterial agent. Synonyms: CP 99433; CP99433; CP-99433. 3-Azabicyclo[3.1.0]hexane, 1,8-naphthyridine-3-carboxylic acid deriv; 1,?8-Naphthyridine-3-carboxylic acid, 7-(6-amino-3-azabicyclo[3.1.0]?hex-3-yl)?-1-cyclopropyl-6-fluoro-1,?4-dihydro-4-oxo-, (1α,?5α,?6α)?-. Grades: 98%. CAS No. 147059-71-0. Molecular formula: C17H17FN4O3. Mole weight: 344.34. | |
| D-Alaninol | A reagent used in the synthesis of naphthyridinone integrase inhibitors. Synonyms: (R)-(-)-2-Amino-1-propanol; (2R)-2-aminopropan-1-ol. Grades: > 95 % by HPLC. CAS No. 35320-23-1. Molecular formula: C3H9NO. Mole weight: 75.10. | |
| Desmethoxyamino Hydroxy Gemifloxacin | Desmethoxyamino Hydroxy Gemifloxacin. Group: Biochemicals. Alternative Names: 7-(3-(Aminomethyl)-4-hydroxypyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid. Grades: Highly Purified. CAS No. 213672-25-4. Pack Sizes: 10mg. Molecular Formula: C17H18FN4O4, Molecular Weight: 362.36. US Biological Life Sciences. | Worldwide |
| Ethyl7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | Heterocyclic Organic Compound. CAS No. 105152-95-2. Catalog: ACM105152952. | |
| FGFR4-IN-1 | FGFR4-IN-1 is a potent and selective FGFR4 inhibitor. FGFR4 may be a novel therapeutic target for gastric cancer. Group: Inhibitors. Alternative Names: FGFR4-IN-1; FGFR4-IN1; FGFR4-IN 1. CAS No. 1708971-72-5. Molecular formula: C24H27N7O5. Mole weight: 493.52. Appearance: Solid powder. Purity: >98%. IUPACName: N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((3-oxomorpholino)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide. Canonical SMILES: O=C (N1CCCC2=CC (CN3C (COCC3)=O)=C (C=O)N=C12)NC4=NC=C (C#N)C (NCCOC)=C4. Catalog: ACM1708971725. | |
| FGFR4-IN-1 | FGFR4-IN-1 is a potent and selective FGFR4 inhibitor with potential for the treatment of gastric cancer. Synonyms: N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((3-oxomorpholino)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide; FGFR4-IN-1; FGFR4-IN1; FGFR4-IN 1. CAS No. 1708971-72-5. Molecular formula: C24H27N7O5. Mole weight: 493.52. | |
| Gemifloxacin-13C2,d2 | Third generation fluorinated quinolone antibacterial. Group: Biochemicals. Alternative Names: 7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid-13C2,d2; SB-265805-13C2,d2; LB-20304-13C2,d2. Grades: Highly Purified. Pack Sizes: 1mg. US Biological Life Sciences. | Worldwide |
| Gemifloxacin Impurity | Gemifloxacin Impurity is an Gemifloxacin impurity, Third generation fluorinated quinolone antibacterial. Synonyms: Desmethoxyamino Hydroxy Gemifloxacin; 7-(3-(Aminomethyl)-4-hydroxypyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic Acid. Grades: > 95%. CAS No. 213672-25-4. Molecular formula: C17H19FN4O4. Mole weight: 362.36. | |
| Gemifloxacin mesilate | Gemifloxacin mesilate. Group: Biochemicals. Alternative Names: 7-[3-(Aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid mesilate; SB-265805 mesilate; LB-20304 mesilate. Grades: Highly Purified. CAS No. 210353-53-0. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C19H24FN5O7S. US Biological Life Sciences. | Worldwide |
| Gemifloxacin Mesylate | Gemifloxacin mesylate, a fluoroquinolone, is an oral broad-spectrum antibacterial agent that has shown strong activity in vitro against a variety of respiratory tract pathogens for the treatment of mild to moderate pneumonia. Synonyms: 1,8-Naphthyridine-3-carboxylic acid, 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-, monomethanesulfonate; Factive; Floxguard; Gemixa; LB 20304a; SB 265805S; 7-[(4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-Naphthyridine-3-carboxylic Acid Monomethanesulfonate; (Z)-Gemifloxacin Mesilate. Grades: ≥95%. CAS No. 210353-53-0. Molecular formula: C19H24FN5O7S. Mole weight: 485.50. | |
| GLPG-0187 | GLPG-0187 is a small molecule integrin receptor antagonist (IRA) with nanomolar affinity for the RGD-integrin receptors αvβ1, αvβ3, αvβ5, αvβ6 and α5β1 (IC50s = 1.2-3.7 nM). Integrin receptors are expressed on the surface of tumor vessel endothelial cells and some types of cancer cells, and play a crucial role in endothelial cell adhesion and migration. This compound shows an inhibitory activity of angiogenesis, bone-resorption and tumor, which is hopefully used as an anticancer drug. Uses: An integrin receptor antagonist (ira) can be used as an anticancer drug. Synonyms: GLPG0187; GLPG 0187; GLPG-0187; UNII-43A5P87Z4T; 43A5P87Z4T; SCHEMBL2372722; CHEMBL3319236; (2S) -3-[[2, 5-dimethyl-6-[4- (5, 6, 7, 8-tetrahydro-1, 8-naphthyridin-2-yl) piperidin-1-yl]pyrimidin-4-yl]amino]-2-[ (4-methoxyphenyl) sulfonylamino]propanoic acid. Grades: ≥98 %. CAS No. 1320346-97-1. Molecular formula: C29H37N7O5S. Mole weight: 595.719. | |
| GNE-495 | GNE-495 is a Selective MAP4K4 (Mitogen-activated protein kinase kinase kinase kinase 4) Inhibitor. IC50 value is 3.7 nM. GNE-495 shows excellent potency and good PK In vivo. GNE-495 was used to demonstrate in vivo efficacy in a retinal angiogenesis model recapitulating effects that are observed in the inducible Map4k4 knockout mice. Synonyms: GNE-495; GNE 495; GNE495. 8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide. Grades: 98%. CAS No. 1449277-10-4. Molecular formula: C22H20FN5O2. Mole weight: 405.43. | |
| INCB086550 | INCB086550 is A Potent and Novel Small-Molecule PD-L1 Inhibitor. In vitro, INCB086550 selectively and potently blocked the PD-L1/PD-1 interaction, induced PD-L1 dimerization and internalization, and induced stimulation-dependent cytokine production in primary human immune cells. In vivo, INCB086550 reduced tumor growth in CD34+ humanized mice and induced T-cell activation gene signatures, consistent with PD-L1/PD-1 pathway blockade. Preliminary data from an ongoing phase I study confirmed PD-L1/PD-1 blockade in peripheral blood cells, with increased immune activation and tumor growth control. Group: Inhibitors. Alternative Names: INCB086550; INCB-086550; INCB 086550; INCB86550; INCB-86550; INCB 86550; PD-1; PD-L1-IN-8. CAS No. 2230911-59-6. Molecular formula: C41H39N7O4. Mole weight: 693.81. Appearance: Solid powder. Purity: >98%. IUPACName: 1-((7-cyano-2-(3'-((3-((3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-yl)amino)-2,2'-dimethyl-[1,1'-biphenyl]-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid. Canonical SMILES: CC1=C (C=CC=C1C2=NC3=CC (=CC (=C3O2)C#N)CN4CCC (C4)C (=O)O)C5=C (C (=CC=C5)NC6=NC=CC7=CC (=CN=C76)CN8CCC (C8)O)C. Catalog: ACM2230911596. | |
| Malaridine | Malaridine. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-((7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino)-2,6-bis(pyrrolidin-1-ylmethyl)phenol. CAS No. 74847-35-1. Molecular Formula: C29H32ClN5O2. Mole Weight: 518.05. Catalog: APB74847351. | |
| MK-0812 | MK-0812 is a potent and selective CCR2 antagonist with low affinity for CCR2 on human monocytes. Synonyms: MK-0812; MK 0812; MK0812; [(1S,3R)-3-[[(3S,4S)-3-methoxyoxan-4-yl]amino]-1-propan-2-ylcyclopentyl]-[3-(trifluoromethyl)-7,8-dihydro-5H-1,6-naphthyridin-6-yl]methanone. CAS No. 624733-88-6. Molecular formula: C24H34F3N3O3. Mole weight: 469.54. | |
| MK-2206 | MK-2206 is an allosteric inhibitor of Akt that prevents translocation of Akt to membranes. It is also an orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B). It binds to and inhibits the activity of Akt in a non-ATP competitive manner, which may result in the inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis. It has potential antineoplastic activity. It exhibits anticancer chemotherapeutic activity in a variety of in vitro cancer models. It induces G1-phase cell cycle arrest in hepatocellular carcinoma cells, inhibits cell proliferation in non-small cell lung cancer cells, and inhibits proliferation in medullary thyroid cancer cells. It also inhibits tumor growth in animal models of nasopharyngeal cancer. It was developed by Merck Sharp & Dohme and in clinic phase 2 trials. Uses: Mk-2206 has potential antineoplastic activity. Synonyms: MK2206; MK 2206; MK-2206; 8-(4-(1-Aminocyclobutyl)phenyl)-9-phenyl-8,9-dihydro-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3(2H)-one;8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one. Grades: 95%. CAS No. 1032349-93-1. Molecular formula: C25H21N5O. Mole weight: 407.47. | |
| MK-2206 (8-(4-(1-Aminocyclobutyl)phenyl-9-phenyl[1, 2, 4]triazolo[3, 4-f][1, 6]naphthyridin-3(2H)-one Dihydrochloride) | A highly selective non-ATP competitive allosteric Akt inhibitor with IC??s of 8nM, 2nM and 65nM for Akt1, Akt2 and Akt3, respectively. MK-2206 potently inhibits phosphorylation of Thr308 and Ser473 in 3T3-L1 adipocytes with IC?? values of 0.11 and 0.18uM, respectively as well as downstream effects of insulin on GLUT4 translocation (IC?? = 0.47uM) and glucose transport (IC?? = 0.14uM). In addition, treatment with MK-2206 causes a robust, concentration-dependent activation of autophagy in human glioma cell lines LN229 and T98G. Group: Biochemicals. Grades: Highly Purified. CAS No. 1032350-13-2. Pack Sizes: 500ug, 1mg. US Biological Life Sciences. | Worldwide |
| MK-2206 dihydrochloride | MK-2206 dihydrochloride. Group: Biochemicals. Alternative Names: 8-[4- (1-Aminocyclobutyl) phenyl]-9-phenyl-1, 2, 4-triazolo[3, 4-f][1, 6]naphthyridin-3 (2H) -one hydrochloride. Grades: Highly Purified. CAS No. 1032350-13-2. Pack Sizes: 25mg, 50mg, 100mg, 250mg, 500mg. Molecular Formula: C25H23Cl2N5O. US Biological Life Sciences. | Worldwide |
| MK-2206 hydrochloride | MK-2206 hydrochloride is the hydrochloride form of MK-2206, which is an allosteric inhibitor of Akt and an orally bioavailable allosteric inhibitor of the serine/threonine protein kinase Akt (protein kinase B). It has potential antineoplastic activity. It exhibits anticancer chemotherapeutic activity in a variety of in vitro cancer models. It inhibits tumor growth in animal models of nasopharyngeal cancer. Uses: Mk-2206 hydrochloride has potential antineoplastic activity. Synonyms: MK-2206 hydrochloride; MK 2206 hydrochloride; 8-[4-(1-Aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one hydrochloride;MK2206 hydrochloride. Grades: >98 %. CAS No. 1032349-77-1. Molecular formula: C25H22ClN5O. Mole weight: 443.93. | |
| mTOR Inhibitor XII, Torin2 (9- (6-aminopyridin-3-yl) -1- (3- (trifluoromethyl) phenyl) benzo[h][1, 6]naphthyridin-2 (1H) -one, DNA-PK Inhibitor VII, PI 3-K Inhibitor XIX, PI 4-K Inhibitor) | A Torin1 structural analog that acts as a cell-permeable, potent, ATP-competitive inhibitor against DNA-PK and mTOR (IC50 = 0.5 and 2.81nM, respectively). Comparing to Torin1, Torin2 displays enhanced inhibitory potency against PI 4-Kbeta (IC50 = 18.3nM) and PI 3-K (IC50 =4.68, 5.67, 8.58, 17.5, 24.5, and 28.1nM, respectively, against P110alpha/P85alpha, P110-gamma, hVPS34, P110delta/P85alpha, C2beta, C2alpha, respectively), while being more effective in inhibiting S6K1 Thr389 phosphorylation in MEF cultures (IC50 = 0.25nM vs 2nM, respectively, for Torin2 and Torin1) in vitro and displaying much improved oral bioavailability in mice (Cmax (ng/mL) /T1/2 (h) = 3968/0.72 and 223/0.79, respectively, for Torin2 and Torin1; 10/mg/kg p.o.) in vivo. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. Molecular Formula: C??H??F?N?O, Primary Target: MTOR. US Biological Life Sciences. | Worldwide |
| OTSSP167 | OTSSP167, also known as OTS167, is an orally available inhibitor of maternal embryonic leucine zipper kinase (MELK) with potential antineoplastic activity. Upon administration, OTS167 binds to MELK, which prevents both MELK phosphorylation and activation; thus inhibiting the phosphorylation of downstream MELK substrates. This may lead to an inhibition of both cell proliferation and survival in MELK-expressing tumor cells. MELK, a serine/threonine kinase, is involved in cancer cell survival, invasiveness and cancer-stem cell formation and maintenance; it is highly upregulated in various types of cancer cells and absent in normal, healthy cells. Synonyms: 1- (6- (3, 5-dichloro-4-hydroxyphenyl) -4- ( ( (1r, 4r) -4- ( (dimethylamino) methyl) cyclohexyl) amino) -1, 5-naphthyridin-3-yl) ethanone; OTSSP167 free base; OTSSP 167; OTSSP-167; OTS167; OTS-167; OTS 167. Grades: 0.98. CAS No. 1431697-89-0. Molecular formula: C25H28Cl2N4O2. Mole weight: 487.425. | |
| OTSSP167 hydrochloride | OTSSP167 is a potent inhibitor of Maternal embryonic leucine zipper kinase (MELK) which regulates neural stem cell selfrenewal through control of the cell cycle. Synonyms: 4-[7-acetyl-8-[[4-[ (dimethylamino) methyl]cyclohexyl]amino]-1H-1, 5-naphthyridin-2-ylidene]-2, 6-dichlorocyclohexa-2, 5-dien-1-one hydrochloride; OTSSP167 (hydrochloride); UNII-65P731R507; 65P731R507; OTSSP167 HCl; OTS-167 monohydrochloride; HY-15512A; AKOS025117447. CAS No. 1431698-10-0. Molecular formula: C25H29Cl3N4O2. Mole weight: 523.9. | |
| PD 131628 | PD 131628 is a new fluoroquinolone as the bioactive form of PD 131112 which is a antibacterial agent originated by Pfizer. PD 131112 can be used for the treatment of infections with penicillin-resistant and -susceptible pneumococci, but no development has been published yet. Uses: Bacterial infections. Synonyms: PD-131628; PD131628; PD 131628; (S)-7-(3-aminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid. Grades: 98%. CAS No. 127967-03-7. Molecular formula: C16H17FN4O3. Mole weight: 332.33. | |
| PD-138312 | PD-138312 is a novel broad-spectrum 7-pyrrolidinyl fluoronaphthyridines with a difluorophenyl substitution or a cyclopropyl at the 1 positions, respectively. It has been demonstrated to have excellent therapeutic potential against clinically important gram-positive pathogens in vitro activity. It was evaluated for its in vivo potencies against acute systemic infections and pneumococcal in mice pneumonia model. Uses: Pd-138312 has been demonstrated to have excellent therapeutic potential against clinically important gram-positive pathogens. Synonyms: PD-138312; PD138312; PD 138312;7-(3-(2-Aminopropan-2-yl)pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid;7-(3-(1-Amino-1-methylethyl)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Grades: >98%. CAS No. 107334-06-5. Molecular formula: C19H23FN4O3. Mole weight: 374.41. | |
| PD 140248 | PD 140248, a fluoronaphthyridine compound, has been found to have potential antibacterial effect especially against gram-positive pathogens. It has not been reported about its development status since 2000. Synonyms: PD-140248; PD140248; PD 140248; 7-(3-(1-Aminoethyl)-1-pyrrolidinyl)-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid; 1,8-Naphthyridine-3-carboxylic acid, 7-(3-(1-aminoethyl-1-pyrrolidinyl))-1-(2,4-difluorophenyl)-6-fluoro-1,4-d. Grades: 98%. CAS No. 147208-55-7. Molecular formula: C21H19F3N4O3. Mole weight: 432.39. | |
| SAR131675 | SAR131675 dose dependently inhibits the proliferation of primary human lymphatic cells, induced by the VEGFR-3 ligands VEGFC and VEGFD, with an IC50 of about 20 nM. Synonyms: (R)-2-amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide; 1,8-Naphthyridine-3-carboxamide, 2-amino-1-ethyl-1,4-dihydro-7-[(3R)-3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl]-N-methyl-4-oxo-. Grades: >98%. CAS No. 1433953-83-3. Molecular formula: C18H22N4O4. Mole weight: 358.39. | |
| SAR131675 | SAR131675 is a potent and selective VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells. SAR131675 also dose dependently inhibited the proliferation of primary human lymphatic cells, induced by the VEGFR-3 ligands VEGFC and VEGFD. Group: Biochemicals. Alternative Names: 2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide; 2-Amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-1,8-naphthyridine-3-carboxamide. Grades: Highly Purified. CAS No. 1092538-80-1. Pack Sizes: 25mg, 50mg. Molecular Formula: C??H??N?O?, Molecular Weight: 358.39. US Biological Life Sciences. | Worldwide |
| SAR131675 (Racemate) | SAR131675 is a potent and selective VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosine kinase activity and VEGFR-3 autophosphorylation in HEK cells with IC50 values of 20 and 45 nmol/L, respectively. Synonyms: (Rac)-SAR131675; 2-Amino-1-ethyl-7-(3-hydroxy-4-methoxy-3-methylbut-1-yn-1-yl)-N-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamide; 1,8-Naphthyridine-3-carboxamide, 2-amino-1-ethyl-1,4-dihydro-7-(3-hydroxy-4-methoxy-3-methyl-1-butyn-1-yl)-N-methyl-4-oxo-, (±)-. Grades: ≥95%. CAS No. 1092539-44-0. Molecular formula: C18H22N4O4. Mole weight: 358.40. | |
| Silmitasertib | Silmitasertib is an orally bioavailable inhibitor of CK2 with potential antineoplastic activity. It inhibits proliferation in cancer cell lines overexpressing CK2. It suppresses survival and induces apoptosis of cancer stem cells including glioblastomas and acute myeloid leukemia cells. Synonyms: CX-4945; CX 4945; 5-((3-Chlorophenyl)amino)benzo[c][2, 6]naphthyridine-8-carboxylic acid. Grades: >98%. CAS No. 1009820-21-6. Molecular formula: C19H12ClN3O2. Mole weight: 349.774. | |
| TC-S 7006 | TC-S 7006 is a potent, selective and reversible Tpl2 (Cot; MAP3K8) inhibitor (IC50 = 50 nM) with selectivity for Tpl2 over MEK, p38, Src, MK2, PKC and EGFR. TC-S 7006 was shown to inhibit LPS-induced TNF-α secretion from primary human monocytes and attenuate acute myeloid leukemia (AML) cell proliferation in vitro. TC-S 7006 also suppresses cytolytic activity of human CD8+ cytotoxic T lymphocytes. Synonyms: 4-[(3-Chloro-4-fluorophenyl)amino]-6-[(3-pyridinylmethyl)amino]-1,7-naphthyridine-3-carbonitrile; TC-S 7006; TC S 7006; TCS 7006; Tpl2 Kinase Inhibitor. Grades: ≥99% by HPLC. CAS No. 871307-18-5. Molecular formula: C21H14ClFN6. Mole weight: 404.83. | |
| Torin 2 | Torin 2. Group: Biochemicals. Alternative Names: 9- (6-Amino-3-pyridinyl) -1-[3- (trifluoromethyl) phenyl]-benzo[h]-1, 6-naphthyridin-2 (1H) -one. Grades: Highly Purified. CAS No. 1223001-51-1. Pack Sizes: 5mg. Molecular Formula: C24H15F3N4O, Molecular Weight: 432.4. US Biological Life Sciences. | Worldwide |
| Torin 2 | Torin 2 is a potent and selective mTOR inhibitor with IC50 of 2.1 nM. It inhibits ATM/ATR/DNA-PK with EC50 of 28 nM/35 nM/118 nM, in PC3 cell lines respectively. It is potentially used as an antineoplastic agent. Synonyms: Torin-2; Torin2; Torin 2; 9-(6-aminopyridin-3-yl)-1-[3-(trifluoromethyl)phenyl]benzo[h][1, 6]naphthyridin-2-one. Grades: 98%. CAS No. 1223001-51-1. Molecular formula: C24H15F3N4O. Mole weight: 432.406. | |
| Tosufloxacin Toluenesulfonate Hydrate | Useful as a therapeutic antimicrobial for the treatment of respiratory infections. Group: Biochemicals. Alternative Names: 7-(3-Amino-1-pyrrolidinyl)-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Toluenesulfonate Hydrate; Tosufloxacin Tosylate; A-64730; T-3262; Ozax; Tosuxacin. Grades: Highly Purified. CAS No. 115964-29-9. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Tosufloxacin tosylate | Tosufloxacin is a fluoroquinolone antibiotic with activity against Gram-positive and Gram-negative aerobic bacteria, anaerobic bacteria and Chlamydia trachomatis. It acts as an inhibitor of bacterial DNA gyrase and topoisomerase IV. Synonyms: Tosuxacin; Ozex; 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid tosylate. Grades: ≥95%. CAS No. 115964-29-9. Molecular formula: C26H23F3N4O6S. Mole weight: 576.543. | |
| Trovafloxacin | Trovafloxacin is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms. Trovafloxacin blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. Trovafloxacin does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1. Group: Inhibitors. Alternative Names: TROVAFLOXACIN;1,8-Naphthyridine-3-carboxylic acid, 7-(1.alpha.,5.alpha.,6.alpha.)-6-amino-3-azabicyclo3.1.0hex-3-yl-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-;(1α,5α,6α)-7-(6-Amino-3-azabi-cyclo[3.1.0]hex-3-y1)-1-(2,4-difluomphenyl)-6-fluom-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid;CP-99219;Trovan:CP-99219-27;7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-keto-1,8-naphthyridine-3-carboxylic acid;7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;7-[(1R,5S)-6-azanyl-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid. CAS No. 147059-72-1. Molecular formula: C20H15F3N4O3. Mole weight: 416.35. Catalog: ACM147059721. | |
| Trovafloxacin mesylate | Trovafloxacin mesylate is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms. Trovafloxacin mesylate blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin mesylate is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. Trovafloxacin mesylate does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin mesylate leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1. Group: Inhibitors. Alternative Names: 7-[(1α,5α,6α)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Methanesulfonate; CP 99219; CP 99219-27; Trovafloxacin Methanesulfonate; Trovafloxacin Monomethanesulfonate; Trovan. CAS No. 147059-75-4. Molecular formula: C20H15F3N4O3. Mole weight: 512.46. Appearance: White Solid. Purity: >99 %. IUPACName: 7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid; methanesulfonic acid. Canonical SMILES: CS (=O) (=O)O. C1C2C (C2N)CN1C3=C (C=C4C (=O)C (=CN (C4=N3)C5=C (C=C (C=C5)F)F)C (=O)O)F. Density: g/cm³. Catalog: ACM147059754. | |
| Trovafloxacin mesylate | Trovafloxacin mesylate is a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. It does not inhibit connexin 43 gap junction or PANX2. It leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1. It is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms. It is also an inhibitor of DNA topoisomerase and gyrase. Uses: Fluorinated quinolone antibacterial. trovafloxacin mesylate blocks the activity of dna gyrase and topoisomerase iv, enzymes essential in the repliction, transcription, and repair of bacterial dna. Synonyms: 7-[(1α,5α,6α)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic Acid Methanesulfonate; CP 99219; CP 99219-27; Trovafloxacin Methanesulfonate; Trovafloxacin Monomethanesulfonate; Trovan; 1,8-Naphthyridine-3-carboxylic acid, 7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-, methanesulfonate (1:1). Grades: ≥95%. CAS No. 147059-75-4. Molecular formula: C21H19F3N4O6S. Mole weight: 512.46. | |
| Trovafloxacin Mesylate | Fluorinated quinolone antibacterial. Trovafloxacin mesylate blocks the activity of DNA gyrase and topoisomerase IV, enzymes essential in the repliction, transcription, and repair of bacterial DNA. Group: Biochemicals. Alternative Names: 7-[(1α, 5α, 6α)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2, 4-difluorophenyl)-6-fluoro-1, 4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic Acid Methanesulfonate; CP 99219; CP 99219-27; Trovafloxacin Methanesulfonate; Trovafloxacin Monomethanesulfonate; Trovan. Grades: Highly Purified. CAS No. 147059-75-4. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
